Pavia e Ansaldo guides GPI´s acquisition of Hemasoft

Pavia e Ansaldo has advised Italy´s GPI on its acquisition of the remaining 40 per cent stake in Spain´s Hemasoft for €5.7 million

GPI S.p.A., a leading company in IT Solutions and Healthcare and Social Services, listed on the MTA market of Borsa Italiana, has announced the acquisition of the residual 40 per cent of shares of its subsidiary Hemasoft Software S.L., leader of the Spanish group of the same name, a deal completed with €5.7 million. GPI is now the sole owner of the Hemasoft Group. Hemasoft Software S.L. holds, in turn, the 100 per cent of shares of Hemasoft America Corporation (Miami, USA). Hemasoft is an international group with branches in Spain and in the USA, it boasts an excellent network of customers and partners in over 50 countries around the world.

The acquisition of the entirety of the Hemasoft Group is a key element in the development of GPI4Blood, the Business Unit of the GPI Group committed to the software solutions for Blood Management that enable the efficient and safe management of Blood Centers, Hospital Blood Banks, Organ, Tissue and Stem Cell Banks and testing laboratories.

GPI was founded over 30 years ago in Trento, Italy, and has grown thanks to significant investments in M&A (in Italy and abroad) and R&D, carried out in partnership with the main Italian universities and research organisations with the aim of transferring scientific, technological, functional and process know-how applied to the e-health, e-welfare, well-being sectors.

Pavia e Ansaldo, an Italian law firm, who opened an office in Barcelona in 2016 to strengthen its presence in Spain, where it has been working for more than 20 years, advised GPU with a team formed by partner and head of the Barcelona office and the Spain´s Desk Meritxell Roca Ortega (pictured) and partner Vittorio Loi (Milan), together with associates Alessandro Tenchini (Barcelona), Fabio Lui (Milan) and Javier Vicente García (Barcelona).

Desire Vidal